Recent advances in consortium-scale genome-wide association studies (GWAS) have highlighted the involvement of common genetic variants in autism spectrum disorder (ASD), but our understanding of their etiologic roles, especially the interplay with rare variants, is incomplete. In this work, we introduce an analytical framework to quantify the transmission disequilibrium of genetically regulated gene expression from parents to offsprings. We applied this framework to conduct a transcriptome-wide association study (TWAS) on 7,805 ASD proband-parent trios, and replicated our findings using 35,740 independent samples. We identified 31 associations at the transcriptome-wide significance level. In particular, we identified POU3F2 (p=2.1e-7), a transcription factor (TF) mainly expressed in developmental brain. TF targets regulated by POU3F2 showed a 2.1-fold enrichment for known ASD genes (p=4.6e-5) and a 2.7-fold enrichment for loss-of-function de novo mutations in ASD probands (p=7.1e-5). These results provide a clear example of the connection between ASD genes affected by very rare mutations and an unlinked key regulator affected by common genetic variations.
Introduction
Autism spectrum disorder (ASD) is a highly heritable neurodevelopmental disorder affecting 1.5% of the world population 1 . It manifests as impaired social interaction and communication, repetitive behavior, and restricted interests with highly heterogenous clinical presentations 2 . Whole-exome sequencing (WES) studies for ASD have identified numerous ultra-rare or de novo singlenucleotide variants, small insertions and deletions (indels), and copy number variants (CNVs) [3] [4] [5] [6] [7] . Although these protein-disrupting genetic variations have large effects on the disease risk, they are only found in a moderate proportion of ASD probands. It has been estimated that the contribution of de novo loss-of-function mutations and CNVs to the variance in ASD liability was only 3% while common genetic variants explain 50% of the variance in the population 8 . Recently, genome-wide association studies (GWAS) with large sample sizes, coupled with novel statistical genetic approaches, have provided new insights into the involvement of common singlenucleotide polymorphisms (SNPs) in ASD. Polygenic risk of ASD is significantly over-transmitted from parents to ASD probands but not their unaffected siblings in simplex families 9 . Such overtransmission was also observed in probands with de novo mutations in known ASD genes. Additionally, a recent GWAS meta-analysis of 18,381 ASD cases and 27,969 controls identified multiple genome-wide significant loci, but did not implicate apparent associations at ASD risk genes identified in WES studies 10 . These results suggested that distinct mechanistic pathways may underlie the ASD risk attributed to rare and common genetic variants, but our understanding of their interplay remains incomplete.
One potential approach to better dissect the genetic basis of ASD is to fine-map candidate genes affected by common SNPs and then investigate how they interact with genes harboring rare pathogenic variants implicated in WES studies. Transcriptome-wide association study (TWAS) is an analytical strategy that integrates expression quantitative trait loci (eQTL) annotations with GWAS data to identify disease genes [11] [12] [13] . Through advanced predictive modeling for gene expression traits, TWAS effectively combines association evidence across many eQTL in diverse tissues and has identified risk genes for numerous complex diseases 14 .
In this study, we introduce TITANS (TrIo-based Transcriptome-wide AssociatioN Study), a novel statistical framework to conduct TWAS in proband-parent trios. Combining recent advances in TWAS modeling and the trio-based study design in ASD cohorts, we demonstrate transmission disequilibrium of genetically regulated gene expression in brain tissues from parents to ASD probands. Specifically, we conducted GWAS and TWAS on 7,805 ASD trios from the Autism Genome Project (AGP), the Simons Simplex Collection (SSC), and the Simons Foundation Powering Autism Research for Knowledge (SPARK) cohort, and replicated our findings in an independent cohort of 13,076 cases and 22,664 controls (Methods). We identified 31 associations at the transcriptome-wide significance level. In particular, we identified POU3F2, a master regulator highly expressed in developmental brain whose downstream target genes are strongly enriched for known ASD genes and mutations.
Figure 1. TITANS workflow. (A)
We generate three matched pseudo siblings for each proband using the phased genotype data of parents and impute gene expression values. (B) We compare the impute gene expression traits between probands and matched pseudosiblings and use conditional logistic regression to quantify the associations. (C) We simulate genotype data for matched pseudosiblings and use conditional logistic regression to assess SNP-disease associations.
Next, using a novel approach called TITANS (Methods), we performed a TWAS with eQTL and splicing quantitative trait loci (sQTL) in 12 brain tissues from the Genotype-Tissue Expression (GTEx) project 15 and the CommonMind consortium (CMC) 16 . For each proband, we generated 3 pseudo siblings using phased genotype data of the parents (Figure 1A) . We imputed gene expression and intron usage values 17 for all probands and pseudo siblings ( Figure 1B) using UTMOST 12 (10 GTEx brain tissues) and FUSION 11 (CMC dorsolateral prefrontal cortex; DLPFC) imputation models. We used conditional logistic regression 18 to assess the transmission disequilibrium of imputed gene expression traits while adjusting for the genetic similarity between probandw and pseudo siblings. We also used the same framework to perform trio-based GWAS (Figure 1C; Table 1 ; Supplementary Figures 2-11 ). 5 associations, i.e. POU3F2 (p=2.1e-7), MSRA (p=5.7e-9), MAPT (p=3.6e-7), KIZ (p=1.9e-7), and NKX2-2 (p=1.5e-10), remained significant after a stringent Bonferroni correction for all genes and all tissues in the analysis (Table 1 and Figure 2 ). In total, these associations implicated 18 unique candidate genes from 7 loci, including 5 novel loci not previously identified in GWAS. No significant associations were identified in unaffected siblingparent trios (Supplementary Figure 12 ) or after randomly shuffling probands and pseudo siblings (Supplementary Figure 13) .
GWAS meta-analysis of trios and case-control cohorts identified 4 genome-wide significant loci (Supplementary Table 2 ), 3 of which (1p21.3, 8p23.1, and 20p11.23) were among previously identified loci 10 . A locus on chromosome 8 is novel but we note that the top SNP did not exist in the trio-based analysis. Overall, association patterns in GWAS and TWAS were concordant (Figure 2) . Two GWAS loci on chromosomes 8 and 20 were also identified in TWAS. No significant associations were found in sibling-parent trios (Supplementary Figure 12 ). 
Candidate risk genes and gene set enrichment analysis
Among the 5 significant genes after a stringent Bonferroni correction for all genes and all tissues in the analysis (Figure 3 and Supplementary Figure 14) , POU3F2 (also known as BRN2) encodes a neural transcription factor with important roles in neurogenesis and brain development 19 . It is a known risk gene for bipolar disorder 20, 21 and has been identified as a master regulator of gene expression changes in schizophrenia and bipolar disorder 22, 23 . Deletions resulting in loss of one copy of POU3F2 cause a disorder of variable developmental delay, intellectual disability, and susceptibility to obesity 24 . Heterozygous POU3F2 knockout mice showed deficits in adult social behavior 25 and it has been linked to neural proliferation phenotypes in stem cell models of ASD 26 . Although this locus did not reach genome-significance in the GWAS, gene-level association at POU3F2 was supported by a SNP-level association peak 700 kb upstream of POU3F2 (Figure 3A ; lead SNP rs2388334, p=1.0e-6). MAPT encodes the microtubule-associated protein tau known to associate with multiple neurodegenerative diseases including Alzheimer's disease and Parkinson's disease 27 and balance of MAPT isoforms is critical for neuronal normal functioning 28 . This locus showed suggestive associations in the GWAS (lead SNP rs2532274, p=6.9e-8). KIZ, NKX2-2, and MSRA are located at 2 loci previously identified in ASD GWAS 10 . KIZ encodes the Kizuna centrosomal protein which is critical for stabilizing mature centrosomes during spindle formation 29 . NKX2-2 encodes the homeobox protein NKX2.2, a transcription factor with an essential role in interpreting graded Sonic hedgehog signals and selecting neuronal identity 30 . MSRA shows high levels of expression in the human central nervous system and Msra knockout mice show abnormal behaviors 31, 32 .
We investigated if genes with nominal associations (p<0.05) in TWAS are enriched in known ASD pathways. Among the 15 gene sets we tested (Methods), only genes encoding postsynaptic density proteins (PSD; enrichment=1.18, p=3.6e-5) and SFARI genes with evidence score 4-6 (enrichment=1.27, p=8.8e-5) showed significant enrichment for TWAS findings after multiple testing correction (Figure 4A; Supplementary Table 3 ). Additionally, we note that some genes with weaker evidence in the SFARI Gene database (see URLs) were identified using samples from the AGP and SSC cohorts and thus may not represent independent evidence. Notably, gene sets that are known to harbor significant burden of rare or de novo variants in ASD, e.g. FMRP target genes (enrichment=1.07, P=0.14), SFARI genes with evidence score S-3 (enrichment=1.07, p=0.24), and chromatin modifier genes (enrichment=0.94, p=0.77), showed negligible enrichment for TWAS associations. These results confirmed the distinct etiologic pathways underlying common and rare genetic variations in ASD. 
TWAS associations in subgroups
Further, we investigated if the effects of candidate genes are consistent in different phenotypic subgroups. We applied TITANS to assess the 31 associations identified in TWAS in sample subgroups stratified by sex and full-scale intelligence quotient (FSIQ) 7, 9 . In sex-stratified analysis of 6,484 male probands and 1,321 female probands, most genes showed comparable effect sizes in males and females (correlation=0.65; Figure 4B ). Cross-tissue significant genes POU3F2, KIZ, and NKX2-2 had higher effects in females. Of note, POU3F2 showed a 1.5-fold ratio between its effects in females and in males, reaching statistical significance even under a substantially smaller sample size of female probands ( Supplementary Table 4 ). This is consistent with a female protection mechanism that requires a larger effect size and risk load. We next performed FSIQstratified analysis and compared the transmission disequilibrium in probands with higher (FSIQ >= 70, N=2,127) and lower FSIQ (FSIQ < 70, N=731). The effect size estimates in two subgroups B C 
Gene set enrichment results
A were mostly consistent (correlation=0.71; Figure 4C ). POU3F2 showed a stronger effect in the subgroup with lower FSIQ (fold=2.00; p=0.023 in subgroup with higher FSIQ, p=0.008 in subgroup with lower FSIQ). 
Regulatory role of POU3F2 in ASD
The transcription factor encoded by POU3F2 is a key regulator in multiple psychiatric disorders 22, 23 . Based on its robust association with ASD in our analysis, we hypothesize that POU3F2 may also play a central role in ASD through its regulatory network. We investigated the biological underpinnings POU3F2 by leveraging diverse types of genomic data. First, we confirmed the link between the gene-level association at POU3F2 and GWAS associations in the same region through integrating fetal brain Hi-C data from the germinal zone (GZ) and postmitoticzone cortical plate (CP) 33 . POU3F2 and the GWAS association peak 700 kb upstream are located in the same topological associating domain (TAD) that is conserved in both GZ and CP zones (chr6: 97.52-99.76 mb; Figure 5A ). Additionally, we identified 59 non-overlapping bins, each of 10 kb in size and within 1 mb from the transcription start site of POU3F2, showing significant interactions with the promoter region of POU3F2 (p<1.0e-4; Methods; Supplementary Tables  5-7) . Multiple bins showing significant interactions with POU3F2 promoter colocalized with GWAS associations in this region. For example, SNP rs62422661 (p=2.0e-5 in GWAS) is located in the bin located at 98.54-98.55mb on chromosome 6 which significantly interacts with POU3F2 in the CP zone (p=2.0e-12). In addition, 15 SNP predictors for POU3F2 expression, including 2 strong predictors with effect sizes ranked at top 15%, are located in bins interacting with POU3F2 promoter (Figure 5A) .
Next, we examined the spatiotemporal expression pattern of POU3F2 in 5 brain regions, i.e. cerebellar cortex (CBC), striatum (STR), hippocampus (HIP), mediodorsal nucleus of thalamus (MD), and amygdala (AMY), spanning from embryonic development to adulthood 34 (Methods). POU3F2 showed significantly elevated expression in developmental brains compared to postnatal brains across all 5 brain regions (p=5.3e-3, permutation test; Figure 5B) . A similar pattern was also observed in several other genes (e.g. MAPT) while NKX2-2 showed elevated expression in postnatal brains (Supplementary Figure 15) .
Additionally, we used the regulatory network developed in Chasman et al. 30 to investigate the enrichment of known ASD genes in target genes regulated by POU3F2. The transcription factor target network of POU3F2 contained 1,013 genes (Figure 5C) . These genes showed strong enrichment (enrichment=2.1, p=0.012) for the SPARK genes which included 153 curated genes known to be associated with autism (Methods; URLs) and for SFARI genes with scores S to 3 (enrichment=2.1, p=4.6e-05). Various gene sets previously shown to enrich for rare and de novo mutations in ASD, including chromatin modifiers (p=2.6e-4), FMRP targets (p=0.009), and lossof-function intolerant genes (p=2.2e-6), were significant enriched in POU3F2 targets ( Supplementary Table 8 ). Furthermore, POU3F2 target genes were significantly enriched for loss-of-function de novo mutations (enrichment=2.68, p=7.1e-05, Poisson test; Methods) in 2,508 SSC probands (Figure 5D, Supplementary Table 9 ). Enrichment remained substantial even after we removed known ASD genes in the SPARK gene list from the analysis (enrichment=1.66, p=0.06) despite the reduced statistical evidence ( Supplementary Table 10 ). We did not observe significant enrichment for missense or synonymous mutations. No enrichment was observed in 1,911 unaffected siblings.
Finally, we obtained transcription factor binding sites (TFBS) of POU3F2 based on the prior network in Chasman et al. 30 and used linkage disequilibrium score regression (LDSC) to assess the enrichment of ASD heritability in these TFBS 35 (Methods). SNPs located near POU3F2 binding sites explained 11.4% of ASD heritability, showing a 5.3-fold enrichment with suggestive statistical significance (p=0.054; Supplementary Table 11 ).
Discussion
In this study, we have presented TITANS, an analytical framework for testing the transmission disequilibrium of genetically regulated molecular traits between parents and probands. Through integrative modeling of GWAS data in trios and rich QTL annotations from large consortia such as GTEx 15 , this approach effectively combines association evidence at multiple SNPs to implicate risk genes affected by common genetic variations. Applied to multiple large-scale ASD cohorts including the SPARK study which has not been previously reported, we conducted a TWAS on 7,805 proband-parent trios and replicated our findings in 35,740 case-control samples. Metaanalysis identified a total of 31 transcriptome-wide significant associations, many of which are located at novel loci not previously implicated in GWAS.
Among the identified associations, convergent evidence suggested a critical etiologic role of POU3F2 in ASD. POU3F2 encodes a transcription factor mainly expressed in the central nervous system 19 and has known key regulatory roles in schizophrenia and bipolar disorder 22, 23 . In our analysis, it reached transcriptome-wide statistical significance in trio-based TWAS and was successfully replicated in the case-control replication. Meta-analysis strengthened the association at POU3F2 and it remained significant after a stringent multiple testing correction for all genes and all tissues analyzed in this study. Subtype analysis suggested that POU3F2 has enhanced over-transmission in female probands (1.5-fold) and individuals with lower FSIQ (2-fold). Furthermore, we demonstrated its etiologic importance and its connection to other ASD risk genes through integrative analysis of diverse types of genomic data. Analysis of fetal brain Hi-C data confirmed significant interactions between POU3F2 promoter and multiple genome regions near GWAS associations located in the same TAD. Analysis of spatiotemporal gene expression data suggested significantly elevated POU3F2 expression in developmental brain. TFBS of POU3F2 were enriched for ASD heritability. Downstream target genes regulated by POU3F2 were enriched for known ASD risk genes identified in WES studies. POU3F2 targets were also significantly enriched for loss-of-function de novo mutations in ASD probands. Enrichment remained substantial even after known ASD genes were removed from the gene set.
WES studies have identified numerous extremely rare, protein-disrupting variants in ASD and have implicated risk genes and pathways [3] [4] [5] [6] [7] . Successful studies focusing on other types of genetic variants using GWAS and whole-genome sequencing approaches have just begun to emerge 9, 10, [36] [37] [38] . A common and somewhat puzzling observation in these studies was that common SNPs associated with ASD did not influence the same genes and pathways enriched for rare variants. Our analysis partly confirmed this observation -genes showing strong associations in TWAS had limited overlap with genes identified through WES. However, the POU3F2 results provide a clear example of the direct link of genes affected by very rare mutations with common genetic variations at a second, unlinked locus. These findings provide insights into the interplay of common and rare genetic variations in ASD, shed light on regulatory network-based modeling of epistatic interactions, and have broad implications for the genetic basis of other diseases.
Methods

Sample information and data processing
We accessed AGP samples through dbGaP (accession: phs000267). The total sample size was 7,880. Genotyping was performed using the Illumina Human 1M-single Infinium BeadChip. Details on these samples have been described elsewhere (see URLs) 39 . We accessed samples from the SSC and the SPARK study through the Simons Foundation Autism Research Initiative (SFARI; see URLs). The SSC cohort contains comprehensive genotype and phenotype information from 2,600 simplex families, each family has one ASD child, and healthy parents and siblings. Genotyping was performed in batches by the Illumina IMv1, IMv3 Duo, and Omni2.5 arrays. Details on these data can be found on the SFARI website (URLs) and have been described elsewhere 38 . Samples in the SPARK study were genotyped by the Illumina Infinium Global Screening Array. Details on these samples have been previously reported 40, 41 and are available on the SFARI website (URLs)
We performed pre-imputation quality control (QC) using PLINK 42 . Only individuals with selfreported European ancestries were included in the study. SNPs with genotype call rate < 0.95, minor allele frequency (MAF) less than 0.01, or significant deviation from Hardy-Weinberg equilibrium (p<1.0e-6) were removed from the analysis. Samples with genotype missing rate > 0.05 were also excluded from the analysis. We used genetic relationship coefficients estimated from GCTA 43 to identify and remove overlapped samples among different cohorts. After QC, 2,188, 1,794, and 3,823 independent proband-parent trios remained in AGP, SSC, and SPARK cohorts respectively. 1,432 and 1,813 trios of sibling-parent trios remained in SSC and SPARK. The UCSC liftOver tool was used to liftover the genome coordinates in AGP samples from hg18 to hg19. The genotype data were phased and imputed to the HRC reference panel version r1.1 2016 using the Michigan Imputation server 44 . We removed SNPs with imputation quality < 0.8 or MAF < 0.01 in the post-imputation QC. 7,260,224 SNPs remained in the AGP study after QC. 7,298,961 SNPs, 7,029,817 SNPs, and 6,866,248 SNPs remained in the SSC 1Mv1, 1Mv3, and Omni2.5 datasets, respectively. 7,031,717 SNPs remained in the SPARK data.
We used case-control samples from the iPSYCH cohort as the replication dataset in our study (13, 076 cases and 22,664 controls) . The iPSYCH ASD sample contains all Danish children born between 1981 and 2005 and details on this cohort are described elsewhere 45 . This cohort has been included in a recent ASD GWAS meta-analysis 10 . Samples in the iPSYCH cohort are independent from samples in the AGP, SSC, and SPARK.
Polygenic transmission disequilibrium analysis
We used the iPSYCH GWAS summary statistics to generate ASD PRS on all samples. We performed a LD-clumping using PLINK with a p-value threshold of 1, a LD threshold of 0.1, and a distance threshold of 1,000 Kb. After clumping, 167085 SNPs remained in the dataset. PRSice was used for PRS calculation 46 . We quantified the transmission disequilibrium of ASD PRS using the pTDT approach 9 .
Trio-based TWAS and GWAS analysis
We developed a statistical framework TITANS to perform trio-based TWAS (Figure 1) . We used UTMOST 12 gene expression imputation models for 10 brain tissues in GTEx and imputation models for CMC DLPFC expression and intron usage values implemented in FUSION 11 . UTMOST model uses a cross-tissue penalized regression model to borrow information from tissues with larger sample size and improve imputation accuracy of gene expression 12 . FUSION trains multiple imputation models in each tissue separately, including Bayesian sparse linear mixed model, elastic net, LASSO, and an ordinary least square model using single best eQTL as the predictor. We selected the best model using the cross-validation.
Given a gene with
predictor SNPs, we extracted those SNPs from parents' phased genotypes and recombined the chromosomes based on Mendelian inheritance to create the genotypes of pseudo siblings. Since only cis-regulators within the local region are included in gene expression and intron usage imputation models, we assumed no crossover events in our analysis. Given the parental data, four recombined pseudo offspring genotypes can be created, each having a paternal haplotype and a maternal haplotype. We imputed gene expression and intron usage on each proband and all four simulated pseudo siblings. We excluded the pseudo sibling whose imputed expression is the closest to the proband's since one of the four simulated offsprings' genotype should be identical to the proband if there is no phasing error or crossover. We tested the association between imputed gene expression and disease phenotype using conditional logistic regression 18 Here, 83 , :'3 , … , :63 denote the imputed gene expression or intron usage values of the proband and 3 pseudo siblings in the i th family. We used the clogit function in the R package 'survival' to numerically estimate the effect size β, which can be interpreted as transmission disequilibrium of imputed expression. The SE of , the z-score test statistic, and association p-value are also reported. TWAS was conducted in the AGP, SSC, and SPARK cohorts separately. Results in different trio-based cohorts were meta-analyzed using the inverse-variance weighted method 47 . These results were then meta-analyzed with the associations in the replication stage using zscore-based meta-analysis weighted by sample sizes 47 .
We performed TWAS in sample subgroups based on sex and FSIQ ( Supplementary Table 4 ). We conducted sex-stratified TWAS in each cohort and meta-analyzed the result across AGP, SSC, and SPARK using the inverse-variance weighted method 47 . FSIQ-stratified analysis based on a cutoff of 70 was conducted in SSC and SPARK separately and then combined through metaanalysis.
We used a similar framework to conduct GWAS in trios. For each SNP, we create four recombined genotypes based on parental data, exclude a genotype identical to the proband's genotype, and perform conditional logistic regression to assess the association between each SNP and ASD status.
Gene set enrichment analysis
We used hypergeometric test to assess if genes with nominal TWAS associations (p<0.05 in any tissue) were enriched in gene sets that have bene linked to ASD in past literatures ( Supplementary Table 3 ). Gene sets assessed in our analysis included co-expression modules M2, M3, M13, M16, and M17 from Parikshak et al. 48 . FMRP targets, genes encoding postsynaptic density proteins (PSD), gene preferentially expressed in human embryonic brains downloaded from BRAINSPAN (see URLs), essential genes 49 , chromatin modifier genes 5 , and genes with probability of loss-of-function intolerance (pLI) > 0.9 from the Exome Aggregation Consortium 50 . In addition, we downloaded genes from the SFARI Gene database on August 2019 (URLs) and created two gene sets based on evidence scores. The gene set based on scores S, 1, 2, or 3 include genes involved in ASD with high to suggestive evidence and genes predisposing to ASD in the context of a syndromic disorder. Genes with scores 4-6 have limited evidence or have only been hypothesized to link to ASD. Finally, we obtained a list of 153 genes with known roles in ASD curated by the SPARK study (URLs). We refer to this gene set of SPARK genes in our analyses.
Hi-C analysis
We used the human fetal brain Hi-C data (URLs; GEO: GSE77565) 33 at resolution 10 kb in the analysis. The samples were sequenced using Illumina HiSeq 2000 chip, collecting from three individuals aging gestation week (GW) 17-18 (one sample from GW17 and two samples from GW18). The Hi-C libraries were constructed in two brain zones GZ and CP. The TAD region of GZ and CP are also provided. We converted the Hi-C contact matrices (HDF5 format) normalized by ICE 51 into the sparse contact matrix format (BED format) and leveraged Fit-Hi-C 52 to detect the significant interactions in the regions of interest. Benjamini-Hochberg procedure 53 was employed to control the false discovery rate.
Spatiotemporal expression analysis
We obtained spatiotemporal GE data for 17 candidate genes with significant associations in our TWAS analysis. Expression data were from 5 brain regions, i.e. CBC, STR, HIP, MD, and AMY, and spanned from 4 PCW to 40 Y as indicated in Kang et al 54 . For 8 -9 PCW specimens, CBC corresponded to the upper (rostral) rhombic lip and adjacent tissue located above the upper rhomboid fossa. STR corresponds to the Medial ganglionic eminence (MGE), Lateral ganglionic eminence (LGE) and caudal ganglionic eminence (CGE). Those regions were sampled separately. For region HIP, specimens were sampled from the hippocampal anlage. MD corresponds to the dorsal part of the thalamic anlage. For 12 PCW -40 PY specimens, CBC was sampled from the lateral part of the posterior lobe. This area contained underlying white matter and all three layers of cerebellar cortex, but deep cerebellar nuclei was excluded. Approximately, CBC corresponds to the lateral pontocerebellum. STR was sampled using the following steps: the anterior part of STR contains the head of the caudate nucleus and the putamen were dissected and separated by the internal capsule and ventrally connected to the nucleus accumbens. Samples include small quantities of surrounding white matter. HIP was sampled from the middle third of the retrocommissural hippocampal formation, located on the medial side of the temporal lobe. MD was sampled from the dorsal and medial thalamus and small quantities of surrounding thalamic nuclei might present in the samples. AMY was sampled from the whole region of AMY. The mRNA-Sequencing was performed using Illumina Genome Analyzer IIx (GAIIx). More details can be found in Li et al 34 .
POU3F2 transcription factor binding network
We downloaded POU3F2 motif position weight matrices (PWM) from 3 databases, CIS-BP 55 , ENCODE 56 , and JASPAR 57 . We accessed DNase-I seq data from Roadmap (GEO: GSE18927). Next, we applied the Protein Interaction Quantification (PIQ) algorithm 58 to identify POU3F2 motif binding sites across the human genome. The PIQ algorithm defines a purity score (500-1000) for motif instances which quantifies the credibility of true motif binding sites.
The transcription factor regulation network were generated with DNase-I seq and PWM as inputs 30 . PIQ motif instances were mapped to the transcription start sites from Gencode v10 within a 10kb radius. The confidence of the edge between a transcription factor and the target was defined as the maximum PIQ purity score among all transcription factor motif instances and the target gene. Furthermore, the confidence score was converted to percentile ranks ranging from 0 to 1. Only edges with confidence score > 0.99 were preserved in the final network, containing 1,029,690 edges among 951 regulators and 25,358 targets.
